Fexuclue for preventing NSAID-related stomach ulcers in everyday use
Part of Digestive system clinical trials.
This study tests a medication called Fexuclue to see how well it prevents stomach ulcers in people who take NSAIDs (common pain relievers) for conditions like arthritis or chronic pain. If you need long-term NSAID therapy, this treatment might help protect your stomach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You need to take NSAIDs (pain relievers like ibuprofen or naproxen) for a health condition.
- You and your doctor agree you need extra protection against stomach ulcers caused by NSAIDs.
- You have been prescribed Fexuclue 20 mg tablets.
- You are not allergic to Fexuclue or its ingredients.
- You are not pregnant or breastfeeding and do not have severe liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called JP-1366 to see if it can prevent stomach ulcers caused by long-term NSAID use (like ibuprofen or naproxen) for conditions such as arthritis. It may be a good fit if you need to take NSAIDs for at least 24 weeks and have a higher risk of ulcers.
This study tests a new medicine called Ilaprazole 10 mg to see if it can prevent stomach ulcers caused by NSAIDs (pain relievers like ibuprofen). If you take NSAIDs regularly and have a higher risk of ulcers, this trial may help protect your stomach.
This study watches patients with acute or chronic gastritis who are already being prescribed the stomach medicine Fexuclu (fexuprazan). It collects information to see how well the medicine works and if it causes any side effects in everyday use.
This trial tests a new medicine, fexuprazan, to see if it can prevent stomach ulcers caused by taking NSAID pain relievers for a long time. If you need daily NSAIDs for arthritis or other muscle/bone pain, this medicine might help protect your stomach.
This trial tests whether fexuprazan can prevent upper gastrointestinal bleeding in people at high risk who need two antiplatelet drugs for at least 6 months after a heart stent. If you are on dual antiplatelet therapy after a stent and have risk factors like older age, low weight, or history of ulcers, this study may help protect your stomach.
This study tests a new medicine to help heal stomach ulcers. It may be an option if you have a stomach ulcer that is not too large and is at a certain stage of healing.
Hear when a new Peptic Ulcer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.